An Open-Label Phase 2a Study to Assess the Safety and Tolerability of Trimetazidine in Patients with Amyotrophic Lateral Sclerosis.

Ruben P A van Eijk,Frederik J Steyn, Mark R Janse van Mantgem, Angela Schmidt, Myrte Meyjes, Sally Allen, Dara V Daygon,Jean-Philippe Loeffler,Ammar Al-Chalabi,Leonard H van den Berg,Robert D Henderson,Shyuan T Ngo

Brain communications（2025）

Cited 0|Views3

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined